Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 12:55 AM
NCT ID:
NCT07245667
Eligibility Criteria:
Inclusion Criteria:
* Male or female, aged 16 or above
* Clinical diagnosis of tinea pedis (For Cohort 4, positive symptomology is acceptable)
* Confirmation of diagnosis with positive potassium hydroxide (KOH) microscopy (For Cohort 4, a negative KOH test is acceptable)
* Signed and dated informed consent form
* Willingness to comply with study protocol and availability for the duration of the study
Exclusion Criteria:
* Diagnosis of moccasin-type tinea pedis
* Presence of serous exudate or pus
* Treatment with a topical antifungal in the past 2 weeks
* Treatment with a systemic antifungal in the past 4 weeks
* Concurrent immunosuppressive or antimicrobial therapy
* Liver disease
* Pregnancy or breastfeeding
* Use any other antifungal therapy during trial or within three months of starting the trial
* Known hypersensitivity to any ingredients of trial agents
* Patients with a current diagnosis of diabetes or neuropathy
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT07245667
Study Brief:
Protocol Section:
NCT07245667